Sanofi (SNY) Long-Term Investments (2009 - 2025)

Sanofi has disclosed Long-Term Investments across 17 years of filings, most recently posting $3.8 billion for Q4 2025.

• Long-Term Investments for Q4 2025 came in at $3.8 billion, up 1023.45% year-over-year; the trailing twelve-month figure through Dec 2025 was $3.8 billion (up 1023.45% YoY), and the FY2025 annual result was $3.8 billion, up 1023.45% from the prior year.
• Long-Term Investments came in at $3.8 billion for Q4 2025 at Sanofi, down from $4.0 billion in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $4.0 billion in Q2 2025 to a low of $257.7 million in Q2 2021.
• The 5-year median for Long-Term Investments is $521.0 million (2023), against an average of $1.2 billion.
• Across the five-year window, Long-Term Investments sank 42.1% in 2024 and jumped 1088.96% in 2025, its largest moves.
• Sanofi's Long-Term Investments stood at $286.0 million in 2021, then surged by 141.51% to $690.7 million in 2022, then tumbled by 33.95% to $456.2 million in 2023, then retreated by 25.98% to $337.7 million in 2024, then jumped by 1023.45% to $3.8 billion in 2025.
• The last three Long-Term Investments figures came in at $3.8 billion (Q4 2025), $4.0 billion (Q2 2025), and $337.7 million (Q4 2024), per Business Quant data.